Skip to main content
Signal8

Sollie-Zetlmayer Hege Elisabeth

SEC insider (Form 3/4/5 filer). CIK 0002142653. Director at PTC THERAPEUTICS, INC. (PTCT). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 28, 2026. Located in WARREN, NJ.

Companies Sollie-Zetlmayer Hege Elisabeth has filed insider reports for

  • PTC THERAPEUTICS, INC. (PTCT): Director
Sollie-Zetlmayer Hege Elisabeth profile photo

Sollie-Zetlmayer Hege Elisabeth

CIK: 0002142653

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PTC THERAPEUTICS, INC. logo
PTCT

PTC THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • PTC THERAPEUTICS, INC. logo
    PTCT

    PTC THERAPEUTICS, INC.

    Jul 28, 2026
    Award
    Direct
    4K shares-
  • PTC THERAPEUTICS, INC. logo
    PTCT

    PTC THERAPEUTICS, INC.

    Jul 28, 2026
    Award
    Direct
    2K shares-

1-2 of 2